Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).

MLA

Alvi, Raza M., et al. “Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).” Journal of the American College of Cardiology, vol. 74, no. 25, Dec. 2019, pp. 3099–108. EBSCOhost, https://doi.org/10.1016/j.jacc.2019.10.038.

APA

Alvi, R. M., Frigault, M. J., Fradley, M. G., Jain, M. D., Mahmood, S. S., Awadalla, M., Lee, D. H., Zlotoff, D. A., Zhang, L., Drobni, Z. D., Hassan, M. Z. O., Bassily, E., Rhea, I., Ismail-Khan, R., Mulligan, C. P., Banerji, D., Lazaryan, A., Shah, B. D., Rokicki, A., … Neilan, T. G. (2019). Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). Journal of the American College of Cardiology, 74(25), 3099–3108. https://doi.org/10.1016/j.jacc.2019.10.038

Chicago

Alvi, Raza M, Matthew J Frigault, Michael G Fradley, Michael D Jain, Syed S Mahmood, Magid Awadalla, Dae Hyun Lee, et al. 2019. “Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).” Journal of the American College of Cardiology 74 (25): 3099–3108. doi:10.1016/j.jacc.2019.10.038.